Mylan Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for additional-strength antipsychotic Haloperidol tablets.

Haloperidol tablets are an antipsychotic typically used to reduce the symptoms of schizophrenia and outbursts associated with Tourette syndrome.

Mylan received approval from the FDA for the tablets in 10mg and 20mg form in addition to Mylan’s currently marketed 0.5mg, 1mg, 2mg and 5mg strengths of the product.